ALLR
Allarity Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.42
−0.70%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-10.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 14, 2026 | Jensen Thomas · officer: CEO | A-Award | 200,000 | $0.00 |
| May 11, 2026 | Hoeiland Jesper · director | A-Award | 25,000 | $0.00 |
| May 7, 2026 | McLaughlin Gerald W. · director | A-Award | 45,000 | $0.00 |
| Apr 30, 2026 | Graff Jeremy R. · officer: See Remarks | A-Award | 133,333 | $0.00 |
| Apr 30, 2026 | Ervin Jeffrey S · officer: CFO | A-Award | 150,000 | $0.00 |
| Jan 16, 2026 | Graff Jeremy R. · officer: See Remarks | A-Award | 133,333 | $0.00 |
| Oct 2, 2025 | Graff Jeremy R. · officer: See Remarks | M-Exempt | 39,494 | $0.00 |
| Oct 2, 2025 | Graff Jeremy R. · officer: See Remarks | F-InKind | 14,613 | $1.58 |
| Jan 24, 2025 | Benjamin Laura · director | A-Award | 25,000 | $1.01 |
| Jan 24, 2025 | McLaughlin Gerald W. · director | A-Award | 25,000 | $1.01 |
| Jan 24, 2025 | Epshinsky Alexander · officer: CFO | A-Award | 29,496 | $0.00 |
| Jan 24, 2025 | Graff Jeremy R. · officer: CDO | A-Award | 144,441 | $0.00 |
| Jan 24, 2025 | Jensen Thomas · officer: CEO | A-Award | 396,734 | $0.00 |
| Jan 24, 2025 | Vazzano Joseph Walter · director | A-Award | 25,000 | $1.01 |
| Oct 1, 2024 | Graff Jeremy R. · officer: See Remarks | A-Award | 118,483 | $2.11 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 14, 2026